Search
Selected: G

Glibenclamide-metformin combination for the treatment of diabete

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glibenclamide-metformin combination for the treatment of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reissue Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glidobactin PF-1 peptide antibiotics

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glomerulonephritis inhibitor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 analogs useful for diabetes treatment

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 derivative and preparation thereof absorbable via...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 exendin-4 peptide analogs and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 formulations with protracted time action

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-1 fusion proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

GLP-2 formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon analogs with ASP.sup.9 replacements or deletions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon analogs with serine replacements

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon analogs with serine replacements

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon analogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon antagonists and methods relating thereto

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon antagonists/inverse agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glucagon antagonists/inverse agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.